(Q52738751)

6 May 2018

title

Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling. (English)

1 reference

6 May 2018

main subject

metabolomic profiling

1 reference

Kevin E Glinton

1

1 reference

6 May 2018

Paul J Benke

2

1 reference

6 May 2018

Matthew A Lines

3

1 reference

6 May 2018

Michael T Geraghty

4

1 reference

6 May 2018

Pranesh Chakraborty

5

1 reference

6 May 2018

Osama Y Al-Dirbashi

6

1 reference

6 May 2018

Yi Jiang

7

1 reference

6 May 2018

Adam D Kennedy

8

1 reference

6 May 2018

Michael S Grotewiel

9

1 reference

6 May 2018

V Reid Sutton

10

1 reference

6 May 2018

Sarah H Elsea

11

1 reference

6 May 2018

Ayman W El-Hattab

12

1 reference

6 May 2018

publication date

12 December 2017

1 reference

6 May 2018

Molecular Genetics and Metabolism

published in

1 reference

6 May 2018

Serine biosynthesis and transport defects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

On the phenotypic spectrum of serine biosynthesis defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

An update on serine deficiency disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Phosphoserine phosphatase (PSPH) gene mutation in an intellectual disability family from Pakistan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Novel neuroglial and glioglial relationships mediated by L-serine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Infantile Serine Biosynthesis Defect Due to Phosphoglycerate Dehydrogenase Deficiency: Variability in Phenotype and Treatment Response, Novel Mutations, and Diagnostic Challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Organization of GC/MS and LC/MS metabolomics data into chemical libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Aromatic L-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Phospholipid methylation in mammals: from biochemistry to physiological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Review: biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Specific requirements of nonbilayer phospholipids in mitochondrial respiratory chain function and formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Molecular mechanisms of axon guidance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Phosphatidylcholine biosynthesis during neuronal differentiation and its role in cell fate determination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Defining the importance of phosphatidylserine synthase-1 (PSS1): unexpected viability of PSS1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Dietary docosahexaenoic acid supplementation modulates hippocampal development in the Pemt-/- mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

D-Serine in neurobiology: CNS neurotransmission and neuromodulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

Comprehensive evaluation of the child with intellectual disability or global developmental delays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2017.12.009

10.1016/J.YMGME.2017.12.009

7 January 2021

Identifiers

DOI

1 reference

6 May 2018

1 reference

6 May 2018